new glp-1 receptor agonists Agonist Services for Type 2 Diabetes and Obesity Drug Development New Molecules and Emerging Indications

Enrollee-by-enrollee eligibility checks on a drug category that Medicare has historically not covered at all

Do GLP-1 analogues have an impact on bone health

51 Gallbladder Disease Rapid weight loss can increase the risk of cholelithiasis and cholecystitis, and was observed in major GLP-1RA trials

Now UCB is taking that same confidence into psoriatic arthritis, against AbbVie's Skyrizi, one of the fastest growing drugs in the industry right now

Eating disorders can lead to serious health complications including heart and kidney problems, and can be life-threatening if not treated properly

API makers have to learn complex creation methods, which requires spending a lot of money on specialized tools and hiring skilled workers